Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg - Net Worth and Insider Trading
Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg owns 6 companies in total, including Syndax Pharmaceuticals Inc (SNDX) , Chiasma Inc (CHMA) , and TriVascular Technologies Inc (TRIV) among others .
Insider Ownership Summary of Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | 2016-03-02 | 10 percent owner |
CHMA | Chiasma Inc | 2015-07-21 | 10 percent owner |
TRIV | TriVascular Technologies Inc | 2014-04-22 | 10 percent owner |
2013-05-30 | 10 percent owner | ||
2013-07-24 | 10 percent owner | ||
2011-02-02 | 10 percent owner |
Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Trading Performance
Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Ownership Network
Ownership Network List of Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg
Ownership Network Relation of Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg
Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg is the 10 percent owner of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 211,420 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,997 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 293,747 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Mailing Address
Above is the net worth, insider trading, and ownership report for Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg. You might contact Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg via mailing address: The John Hancock Tower, 200 Clarendon Street, 54th Floor, Boston Ma 02116.